# Do CCR5 Antagonists Improve the Overall Survival of Patients With AIDS-related Progressive Multifocal Leucoencephalopathy?

> **NCT03969550** · — · COMPLETED · sponsor: **Fondation Ophtalmologique Adolphe de Rothschild** · enrollment: 34 (actual)

## Conditions studied

- AIDS
- Progressive Multifocal Leucoencephalopathy (PML)

## Interventions

- **OTHER:** Measure of overall survival

## Key facts

- **NCT ID:** NCT03969550
- **Lead sponsor:** Fondation Ophtalmologique Adolphe de Rothschild
- **Sponsor class:** NETWORK
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-01
- **Primary completion:** 2015-12
- **Final completion:** 2015-12
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2019-05-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03969550

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03969550, "Do CCR5 Antagonists Improve the Overall Survival of Patients With AIDS-related Progressive Multifocal Leucoencephalopathy?". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT03969550. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*